SkyPharma Biopharmaceutical Facility

The SkyePharma Biopharmaceutical Facility included approximately 36,000 sq. ft. of liquid pharmaceutical manufacturing space which required certification by the United States Food and Drug Administration. Approximately 25,000 sq. ft. of the facility was finished included FDA approved controlled substance receipt and storage. The balance of the 83,000 sq. ft. building is used as administrative space. Lankford&Associates,Inc. managed all aspects of the project including all interior construction.